A Clinical Study for Assessment of the Efficacy and Safety of Mirtazapine (Smilon) in Depression Patients With Pain
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the Efficacy and Safety of Smilon® in the Depression
Patients with pain. Eligible patients will be randomly assigned to 1 of 2 arms, either
Smilon® or placebo, and will receive the treatment for 8 weeks in this study.